MedDataX Logo

Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial

NCT ID: NCT04330768

Last Updated: 2020-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-31

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

platelet rich fibrin(PRF) obtained from patient from patient blood sample (before start of treatment)is injected in the site of exposure of exposure(intervention group) control group will receive normal pulp capping procedure by MTA follow up will be one year

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparative Evaluation of the Regenerative Capacity of Two Platelet Concentrates

NCT03698188

Necrotic Pulp
UNKNOWN NA

Clinical and Radiographic Assessment of Platelet Rich Fibrin and Mineral Trioxide Aggregate as Pulp Capping Biomaterials

NCT04488679

Direct Pulp Capping
COMPLETED NA

Clinical and Radiographic Evaluation of Indirect Pulp Capping Using Platelet Rich Fibrin Versus Mineral Trioxide Aggregate in Deep Carious Molars: a Randomized Controlled Trial

NCT06889363

Dental Caries Pulp Caping Indirect Pulp Treatment +7 more
NOT_YET_RECRUITING PHASE2

Evaluation of Platelet-rich Fibrin for Revascularization of Immature Permanent Teeth Versus Standard Apexification

NCT06693349

To Evaluate the Clinical and Radiographic Effect of Platelet-rich Fibrin in Treatment of Necrotic Permanent Teeth with Open Apices
COMPLETED PHASE3

Outcome of Pulp Revascularization of Necrotic Mature Permanent Teeth Using Platelet-rich Fibrin

NCT06347640

Pulp Revascularization
RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

intervention group:patient with deep caries lesion ,free from sign and symptoms of irreversible pulpitis the blood sample will be taken before the beginning of dental treatment..PRF will be obtained by blood centrifugal and injected in the site of exposure covered by glass ionomer restoration control group: patient with same condition will receive pulp capping procedure by MTA followed by glass ionomer restoration

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Pulp Exposure Dental Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PRF

Group Type EXPERIMENTAL

PRF pulp capping

Intervention Type PROCEDURE

PRF is injected in the site of exposure

MTA

Group Type ACTIVE_COMPARATOR

MTA pulp capping

Intervention Type PROCEDURE

conventional pulp capping procedure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PRF pulp capping

PRF is injected in the site of exposure

Intervention Type PROCEDURE

MTA pulp capping

conventional pulp capping procedure

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* deep carious lesion- no sign of irreversible pulpitis

Exclusion Criteria

* old age- periapical lesion-
Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dina mounir elkady

Lecturer at conservative department

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0555

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Alveolar Ridge Preservation Following Tooth Extraction Using Advanced Platelet Rich Fibrin (A-PRF) Versus Platelet Rich Fibrin (PRF)
NCT04434703 UNKNOWN NA
Effect of Injectable Platelet-rich Fibrin on the En Masse Retraction of Maxillary Anterior Teeth
NCT05608356 UNKNOWN NA
Efficacy of Combined Blood Clot and Platelet Rich Fibrin Scaffolds in Regeneration of Necrotic Immature Permanent Teeth
NCT04390854 COMPLETED PHASE2
Furcation Treatment With L-PRF and aPDT
NCT04842188 COMPLETED NA
The Use of PRF in the Management of Soft Tissue Healing
NCT04212767 COMPLETED NA
Comparison Between Two Regenerative Scaffolds
NCT06227533 COMPLETED NA
Treated Dentine Matrix and Platelet Rich Fibrin in Induction of Root Formation of Non-Vital Immature Permanent Teeth
NCT05775081 COMPLETED NA
The Use of Platelet Rich Fibrin in Pulpal and Periodontal Regeneration in Mature Teeth
NCT02477358 COMPLETED NA
Immediately Placed Implant Sealed With Platelets Rich Fibrin Versus Cyanoacrylate Glue
NCT05437744 UNKNOWN NA
Prevention of Mandibular Third Molar Extraction- Associated Periodontal Defects Using Platelet-Rich Fibrin
NCT04033744 COMPLETED NA
Advanced PRF vs PRF for Gap Filling in Immediate Implants
NCT07319494 ACTIVE_NOT_RECRUITING NA
Use of Injectable Extended Platelet-Rich Fibrin as a Local Drug Delivery in the Treatment of Stage II Periodontitis Patients
NCT07080294 COMPLETED NA
Pinhole Surgical Technique for Root Coverage Using PRF
NCT04202198 UNKNOWN PHASE2
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
NCT02430519 COMPLETED NA
Using of Injectable Platelet Rich Fibrin on Filling the Gap of Immediate Dental Implant
NCT04298294 COMPLETED NA
Evaluation of Different Scaffolds in Regenerative Endodontic Treatment
NCT06945965 COMPLETED NA
Effect of Monolayer Versus Multilayer Leucocyte-Platelet Rich Fibrin (L-PRF) in Interdental Papillary Reconstruction
NCT04091802 COMPLETED NA
Use of Platelet Rich Fibrin in Addition to CAF and SCTG for Treatment of Gingival Recession
NCT03199118 COMPLETED NA
Treatment of Deficient Interdental Papilla Using Albumin-platelets Rich Fibrin
NCT06842277 ACTIVE_NOT_RECRUITING PHASE2
Regenerative Endodontic Procedure of Immature Permanent Teeth With Apical Periodontitis Using PRF
NCT02801552 COMPLETED NA
The Use of Leucocyte Platelet Rich Fibrin (L- PRF) Covered Perforated Guided Tissue Membrane for Treatment of Periodontal Intrabony Defects
NCT04576468 COMPLETED NA
Assessment of Keratinized Gingiva With and Without PRF Application in Patients With Dental Implant
NCT04864197 UNKNOWN PHASE3
Growth Factors Release of PRF and PRGF
NCT02447510 COMPLETED PHASE3
Injectable Platelet Rich Fibrin With Demineralized Freeze-dried Bone Allograft in Treatment of Intraosseous Defects
NCT03900013 UNKNOWN NA
Platelet Rich Plasma in Healing of Through and Through Periradicular Lesions
NCT03430557 UNKNOWN NA